Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Processa Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q3 2023
- Shares held
- 1.13M
- −255.3K (−18.4%) vs. Q3 2023
- Total value
- $376.5K
- +$26.7K (+7.6%) vs. Q3 2023
- New holders
- 4
- 6 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 315,410 | $105.5K | 0.00% | +149,186+89.7% | Added |
| Vanguard Group Inc | 234,653 | $78.5K | 0.00% | −109,772−31.9% | Reduced |
| Geode Capital Management, LLC | 122,033 | $40.8K | 0.00% | −30,637−20.1% | Reduced |
| UBS Group AG | 80,023 | $26.8K | 0.00% | +79,316+11,218.7% | Added |
| Spinnaker Trust | 76,865 | $25.7K | 0.00% | +76,865 | New |
| Coastal Bridge Advisors, LLC | 64,956 | $21.7K | 0.01% | +12,456+23.7% | Added |
| Renaissance Technologies LLC | 58,200 | $19.0K | 0.00% | +4,300+8.0% | Added |
| Royal Bank of Canada | 46,306 | $15.0K | 0.00% | −76−0.2% | Reduced |
| State Street Corp | 42,786 | $14.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,139 | $9.41K | 0.00% | +12,738+82.7% | Added |
| Two Sigma Investments, LP | 18,677 | $6.25K | 0.00% | +18,677 | New |
| McCollum Christoferson Group LLC | 12,500 | $4.18K | 0.00% | +12,500 | New |
| Courier Capital LLC | 12,000 | $4.01K | 0.00% | +12,000 | New |
| HRT Financial LP | 11,717 | $3.00K | 0.00% | −7,629−39.4% | Reduced |
| Wells Fargo & Company | 3,247 | $1.09K | 0.00% | +9+0.3% | Added |
| Allworth Financial LP | 1,700 | $569 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,195 | $400 | 0.00% | −8,899−88.2% | Reduced |
| BlackRock Inc. | 293 | $98 | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 0 | $0 | 0.00% | −419,277−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,930−100.0% | Sold out |
| Mirador Capital Partners LP | 0 | $0 | 0.00% | −19,516−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,617−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |